Specialized Biotechnology Focus ZATA Pharmaceuticals operates in a niche within the pharmaceutical manufacturing industry, specializing in oligotherapeutics, cardiovascular drugs, transfusion medicine, and antipathogens. This targeted expertise presents opportunities to offer advanced laboratory instruments, research collaboration tools, and specialized raw materials tailored to their R&D efforts.

Emerging Start-Up with Growth Potential As a biotech startup founded in 2009 with a small team of 2-10 employees, ZATA is poised for expansion and investment. Providing scalable production solutions, biotech equipment, or interim staffing services could support their growth trajectory and research scale-up needs.

Digital Presence & Tech Stack ZATA utilizes various digital tools like Google Analytics, Tag Manager, and PayPal Marketing Solutions, indicating active digital engagement. Marketing technology providers, webinar platforms, and data analytics services could capitalize on their digital marketing efforts to enhance outreach or streamline their online research collaborations.

Funding and Revenue Range With a revenue estimate between 1 million and 10 million dollars, ZATA is still in a growth phase, which could make them receptive to customized funding or investment opportunities, including grants, venture capital partnerships, or strategic alliances to accelerate product development.

Market and Collaboration Opportunities Given their collaboration with various entities like Dexa Group and focus on innovative drug development, ZATA may benefit from partnerships in clinical trials, research outsourcing, or equipment procurement, providing tailored scientific solutions to support their pharmaceutical innovations.